Bulletin
Investor Alert

Leidos Holdings Inc.

NYS: LDOS

GO
/marketstate/country/us

After Hours

 --Quotes are delayed by 20 min

Jul 10, 2020, 7:58 p.m.

/zigman2/quotes/202902477/composite

$

88.40

Change

+0.49 +0.56%

Volume

Volume 37,725

Quotes are delayed by 20 min

/zigman2/quotes/202902477/composite

Previous close

$ 86.41

$ 87.91

Change

+1.50 +1.74%

Day low

Day high

$86.51

$88.10

Open

52 week low

52 week high

$68.00

$125.84

Open

Insider Actions for Leidos Holdings Inc.

– Purchase – Sale 1 – Number of Transactions
Date Name Shares Transaction Value
07/08/2020 Miriam E. John
Director
398   Award at $87.89 per share. 34,980
06/30/2020 Roger A. Krone
CEO; Director
411   Award at $0 per share. 0
06/30/2020 Harry M. Jansen Kraemer
Director
422   Award at $0 per share. 0
06/30/2020 James Corbett Reagan
EVP, Chief Financial Officer
281   Award at $0 per share. 0
06/30/2020 Miriam E. John
Director
256   Award at $0 per share. 0
06/30/2020 James R. Moos
Group President
8   Award at $0 per share. 0
06/30/2020 Christopher R. Cage
SVP and Corporate Controller
81   Award at $0 per share. 0
06/30/2020 Jerald S. Howe
Executive VP & General Counsel
16   Award at $0 per share. 0
06/30/2020 Frank Kendall
Director
18   Award at $0 per share. 0
06/10/2020 Miriam E. John
Director
2,556   Disposition at $105.89 per share. 270,654
05/27/2020 Stevens Roy E
Chief of Business Development
2,801   Disposition at $101.23 per share. 283,545
05/26/2020 Stevens Roy E
Chief of Business Development
4,699   Derivative/Non-derivative trans. at $100.96 per share. 474,411
05/26/2020 Stevens Roy E
Chief of Business Development
7,500   Derivative/Non-derivative trans. at $39.7 per share. 297,750
05/20/2020 Harry M. Jansen Kraemer
Director
2,379   Derivative/Non-derivative trans. at $97.82 per share. 232,713
05/20/2020 Harry M. Jansen Kraemer
Director
8,251   Derivative/Non-derivative trans. at $28.19 per share. 232,595
05/15/2020 Miriam E. John
Director
2,428   Derivative/Non-derivative trans. at $95.83 per share. 232,675
05/15/2020 Miriam E. John
Director
8,251   Derivative/Non-derivative trans. at $28.19 per share. 232,595
05/11/2020 Lawrence C. Nussdorf
Director
8,251   Derivative/Non-derivative trans. at $28.19 per share. 232,595
05/11/2020 David G. Fubini
Director
4,865   Disposition at $102.8 per share. 500,122
05/11/2020 Gary Stephen May
Director
600   Disposition at $102.27 per share. 61,362
05/08/2020 Harry M. Jansen Kraemer
Director
1,047   Award at $0 per share. 0
05/08/2020 Miriam E. John
Director
1,047   Award at $0 per share. 0
05/08/2020 Lawrence C. Nussdorf
Director
1,047   Award at $0 per share. 0
05/08/2020 Robert S. Shapard
Director
1,047   Award at $0 per share. 0
05/08/2020 Noel Brown Williams
Director
1,047   Award at $0 per share. 0
05/08/2020 Surya Narayan Mohapatra
Director
1,047   Award at $0 per share. 0
05/08/2020 David G. Fubini
Director
1,047   Award at $0 per share. 0
05/08/2020 Gary Stephen May
Director
1,047   Award at $0 per share. 0
05/08/2020 Susan M. Stalnecker
Director
1,047   Award at $0 per share. 0
05/08/2020 Gregory R. Dahlberg
Director
1,047   Award at $0 per share. 0
05/08/2020 Frank Kendall
Director
1,047   Award at $0 per share. 0
05/08/2020 Robert C. Kovarik
Director
1,047   Award at $0 per share. 0
05/01/2020 Harry M. Jansen Kraemer
Director
19   Award at $98.81 per share. 1,877
05/01/2020 Miriam E. John
Director
19   Award at $98.81 per share. 1,877
05/01/2020 Frank Kendall
Director
19   Award at $98.81 per share. 1,877

Transaction Summary

Total insider purchases and sales reported to the SEC

Timeframe Transactions Shares
Last 3 months
28 Purchases
7 Sales
46,765
20,328
Last 6 months
71 Purchases
58 Sales
304,656
149,497
Last 12 months
90 Purchases
68 Sales
332,818
179,892

Officers and Executives

Mr. Roger A. Krone
Chairman & Chief Executive Officer
Mr. James Corbett Reagan
Chief Financial Officer & Executive VP
Mr. James F. Carlini
Chief Technology Officer
Dr. Donald Kosiak
Chief Medical Officer
Mr. Steve Hull
Chief Information Officer & Senior Vice President
Ms. Sharon G. Watts
Chief Administrative Officer
Mr. Michael Jackman
Chief Operating Officer-Health Group
Mr. James R. Moos
President-Civil Group
Mr. Roy Stevens
EVP, Chief Business Development & Strategy
Mr. Ranjit S. Chadha
Senior VP-Financial Planning & Analysis
Mr. Gerry Fasano
President & EVP-Defense Group
Ms. Michele M. Brown
Chief Ethics & Compliance Officer, Senior VP
Dr. James Cantor
Chief of Performance Excellence & Strategic
Mr. Randy E. Phillips
Senior Vice President-Corporate Development
Mr. Gregory R. Dahlberg
Director
Mr. Robert C. Kovarik
Director
Mr. Christopher R. Cage
Chief Accounting Officer & Controller
Ms. Kelly Freeman
Investor Relations Contact
Mr. Paul O. Engola
Chief Human Resources Officer & Senior VP
Mr. Raymond L. Veldman
Secretary & Senior Vice President
Mr. Jerald S. Howe
Executive Vice President & General Counsel
Mr. Rob Thomas
VP-Strategic Accounts & Government Relations
Ms. Melissa Koskovich
Senior Vice President-Communications
Mr. Lawrence C. Nussdorf
Lead Independent Director
Mr. David G. Fubini
Independent Director
Mr. Robert S. Shapard
Lead Independent Director
Ms. Noel Brown Williams
Independent Director
Dr. Gary Stephen May
Independent Director
Mr. Harry M. Jansen Kraemer
Independent Director
Dr. Surya Narayan Mohapatra
Independent Director
Ms. Susan M. Stalnecker
Independent Director
Dr. Miriam E. John
Independent Director
Mr. Frank Kendall
Independent Director
Link to MarketWatch's Slice.